AIM-TumorCellularity (AIM-TC)

AIM-TC¹ is PathAI’s pan-tumor product that quantifies the areas of tumor and tissue, and supports tumor cellularity assessments required for successful NGS. AISight®, PathAI’s digital pathology image management system, enables access to a menu of algorithm products that can be utilized to increase efficiency and turnaround time of routine laboratory tasks.

Increase success rate of NGS

Run on a standard H&E whole slide image, AIM-TC can automatically determine the tumor area and percentage of tumor nuclei.

Streamline Review

Tumor cellularity assessment can be time consuming, particularly when tumor content is low. AIM-TC may reduce the amount of pathologist time spent on tumor cellularity assessments.

Automate Assessment

AIM-TC provides standardized, quantitative metrics to support more accurate determination of tissue inputs.

"AIM-TC is a great example of how AI can augment the pathology laboratory and eliminate routine, stressful and time-consuming activities, allowing pathologists to focus on what they do best. We expect that if implemented widely in our practice, AIM-TC can save hundreds of hours of pathologist time that can instead be used for case sign-off and patient care."

- Tobias Kull, PhD., bioinformatician in the Molecular Pathology Unit of University Hospital Zurich

Pathologist-Centric Visualization & Quantification

The model is designed around the pathologist’s workflow, with optional H&E overlays that stay off by default and can be enabled on demand to clearly highlight tumor regions and support single-cell–level tumor cell quantification as the user zooms in.

Tumor Sufficiency Outputs in the Side Panel

Provides key tumor sufficiency outputs for molecular testing in a convenient side panel for quick review.

Annotation Insights

Allows users to draw regions of interest and view supported AI results in real time to enable faster area-specific quantification and reduce repetitive counting.